Hypoactive Sexual Desire Disorder
📧 Sign up to get email alerts when something new happens for Hypoactive Sexual Desire Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Hypoactive Sexual Desire Disorder in Males [Phase 2]
A Phase 2 clinical trial for hypoactive sexual desire disorder in males was terminated, with the study sponsor listed as Mohit Khera and the…
-
CLINICAL_TRIALS trial_result · 2024-11-13Clinical Trial Update: A Phase 3, Bridging, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate the Efficacy and Safety of Subcutaneously Administered Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder (With or Without Decreased Arousal) [Phase 3]
Phase 3 trial of subcutaneously administered Bremelanotide in premenopausal women with Hypoactive Sexual Desire Disorder has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: Role of the Melanocortin-4 Receptor in Hypoactive Sexual Desire Disorder [Phase 4]
A Phase 4 clinical trial examining the role of the melanocortin-4 receptor in hypoactive sexual desire disorder has completed, with results …
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Effects of Flibanserin on the Pre- and Post-menopausal Female Brain [NA]
This terminated trial evaluated the effects of flibanserin on the brain of pre- and post-menopausal women with hypoactive sexual desire diso…
-
CLINICAL_TRIALS trial_result · 2022-06-13Clinical Trial Update: Flibanserin (Addyi®) vs. Flibanserin and Sex Therapy [Phase 4]
Phase 4 trial comparing flibanserin alone versus flibanserin with sex therapy in hypoactive sexual desire disorder; study terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-10-29Clinical Trial Update: Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women [Phase 3]
Phase 3 clinical trial update on LibiGel for hypoactive sexual desire disorder in postmenopausal women reports safety and efficacy results.
-
CLINICAL_TRIALS trial_result · 2021-04-09Clinical Trial Update: Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) [Phase 3]
Phase 3 trial of prasterone (DHEA) for hypoactive sexual desire disorder has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-28Clinical Trial Update: 2. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of bremelanotide for hypoactive sexual desire disorder in premenopausal women has …
-
CLINICAL_TRIALS trial_result · 2020-12-23Clinical Trial Update: 1. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder [Phase 3]
Phase 3 trial evaluating the efficacy and safety of Bremelanotide in premenopausal women with hypoactive sexual desire disorder has complete…
-
CLINICAL_TRIALS trial_result · 2020-02-11Clinical Trial Update: BP101 for Adults With Female Sexual Dysfunction [Phase 3]
Phase 3 clinical trial update for BP101 in adults with hypoactive sexual desire disorder and female sexual dysfunction has completed.
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: Testosterone Patch's Effects on the Cardiovascular System and Libido [Phase 4]
Phase 4 trial update on a testosterone patch assessing cardiovascular effects and libido in hypoactive sexual desire disorder.
-
CLINICAL_TRIALS trial_result · 2019-07-12Clinical Trial Update: Bupropion in Sexual Dysfunction Among Methadone Maintenance Treatment Men [Phase 2]
Phase 2 trial investigating bupropion for sexual dysfunction in men on methadone maintenance; study completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: Study of the Efficacy and Safety of BP101 in Female Patients With Decrease or Loss of Sexual Desire [Phase 2]
Phase 2 study of BP101 in women with Hypoactive sexual desire disorder has completed. The update reports on efficacy and safety findings fro…
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: 6-mo. Min Eff Dose of Flibanserin: 25 v 50 mg Bid v 50 mg hs v Pbo in Younger Women in NA [Phase 3]
Phase 3 trial evaluating the minimum effective dose of flibanserin (25 mg BID, 50 mg BID, 50 mg at bedtime) versus placebo over six months i…
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: Uptitration Trial of Flibanserin Versus Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder [Phase 3]
This is a Phase 3 uptitration trial comparing Flibanserin to placebo in premenopausal women with hypoactive sexual desire disorder. Results …
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: 24-week Placebo-controlled Trial of Flibanserin Once Daily in Premenopausal Women With Hypoactive Sexual Desire Disorder [Phase 3]
A Phase 3, 24-week, placebo-controlled trial of flibanserin in premenopausal women with hypoactive sexual desire disorder has completed and …
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: The Effect of Individualised Homeopathic Treatment on Low Sexual Desire in Perimenopause [Phase 2]
University of Johannesburg completed a Phase 2 trial evaluating individualized homeopathic treatment for hypoactive sexual desire disorder i…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Efficacy and Safety of Oral DHEA Therapy for Postmenopausal Women on Sexual Function, Wellbeing and Vasomotor Symptoms [Phase 3]
A Phase 3 trial evaluating oral dehydroepiandrosterone (DHEA) for postmenopausal women has completed, assessing effects on sexual function, …
-
CLINICAL_TRIALS trial_result · 2016-01-14Clinical Trial Update: Effects of Tribulus Terrestris in Women With Hypoactive Sexual Desire Disorder [Phase 4]
Phase 4 clinical trial evaluating Tribulus Terrestris in women with hypoactive sexual desire disorder has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Surveillance Study of Women Taking Intrinsa®
The surveillance study of women taking Intrinsa (testosterone transdermal patch) has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-03-24Clinical Trial Update: Lybridos in Pre-and Postmenopausal Women With Hypoactive Sexual Desire Disorder [Phase 2]
A Phase 2 clinical trial of Lybridos in pre- and postmenopausal women with hypoactive sexual desire disorder has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: Efficacy and Safety of Oral Dehydroepiandrosterone as a Concomitant Therapy to Oral Contraceptives in Women Complaining of Reduced Libido [Phase 2]
Phase 2 trial evaluated the efficacy and safety of adding oral dehydroepiandrosterone (DHEA) to oral contraceptives in women with reduced li…
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: Effects of Early Abuse on Adult Intimate Relationships [NA]
This clinical trial update indicates the study on the effects of early abuse on adult intimate relationships has completed. It included cond…
-
CLINICAL_TRIALS trial_result · 2014-10-28Clinical Trial Update: Phase 1b/2a Unblinded Study of Responses in Premenopausal Women With HSDD to Lorexys Evaluating Efficacy and Safety [Phase 1, Phase 2]
Phase 1b/2a unblinded study evaluating efficacy and safety of Lorexys in premenopausal women with hypoactive sexual desire disorder and sexu…
-
CLINICAL_TRIALS trial_result · 2014-10-17Clinical Trial Update: Acupuncture for Sexual Dysfunction [NA]
This clinical trial update notes that an acupuncture study for Hypoactive Sexual Desire Disorder and related Female Sexual Dysfunction has c…